In MM patients with 1q+, those with a higher CDC5L mRNA expression level exhibited a worse prognosis in terms of progression-free survival (P = 0.001) and overall survival (P = 0.004) as compared with patients with a lower CDC5L mRNA level. The gene discussed is CDC5L; the disease is Miyoshi myopathy.